Literature DB >> 32855146

Attention deficit hyperactivity disorder in adults: common in primary care, misdiagnosed, and impairing, but highly responsive to treatment.

Sally Cubbin1, Laurence Leaver2, Allyson Parry3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32855146      PMCID: PMC7449447          DOI: 10.3399/bjgp20X712553

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  4 in total

Review 1.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

Authors:  Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

2.  The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.

Authors:  Ronald C Kessler; Lenard Adler; Minnie Ames; Olga Demler; Steve Faraone; Eva Hiripi; Mary J Howes; Robert Jin; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters
Journal:  Psychol Med       Date:  2005-02       Impact factor: 7.723

3.  Updated European Consensus Statement on diagnosis and treatment of adult ADHD.

Authors:  J J S Kooij; D Bijlenga; L Salerno; R Jaeschke; I Bitter; J Balázs; J Thome; G Dom; S Kasper; C Nunes Filipe; S Stes; P Mohr; S Leppämäki; M Casas; J Bobes; J M Mccarthy; V Richarte; A Kjems Philipsen; A Pehlivanidis; A Niemela; B Styr; B Semerci; B Bolea-Alamanac; D Edvinsson; D Baeyens; D Wynchank; E Sobanski; A Philipsen; F McNicholas; H Caci; I Mihailescu; I Manor; I Dobrescu; T Saito; J Krause; J Fayyad; J A Ramos-Quiroga; K Foeken; F Rad; M Adamou; M Ohlmeier; M Fitzgerald; M Gill; M Lensing; N Motavalli Mukaddes; P Brudkiewicz; P Gustafsson; P Tani; P Oswald; P J Carpentier; P De Rossi; R Delorme; S Markovska Simoska; S Pallanti; S Young; S Bejerot; T Lehtonen; J Kustow; U Müller-Sedgwick; T Hirvikoski; V Pironti; Y Ginsberg; Z Félegyházy; M P Garcia-Portilla; P Asherson
Journal:  Eur Psychiatry       Date:  2018-11-16       Impact factor: 5.361

4.  Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.

Authors:  Samuele Cortese; Nicoletta Adamo; Cinzia Del Giovane; Christina Mohr-Jensen; Adrian J Hayes; Sara Carucci; Lauren Z Atkinson; Luca Tessari; Tobias Banaschewski; David Coghill; Chris Hollis; Emily Simonoff; Alessandro Zuddas; Corrado Barbui; Marianna Purgato; Hans-Christoph Steinhausen; Farhad Shokraneh; Jun Xia; Andrea Cipriani
Journal:  Lancet Psychiatry       Date:  2018-08-07       Impact factor: 27.083

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.